The Breast
Volume 19, Issue 6 , Pages 516-520 , December 2010

Investigation of anaphylactic reaction after patent blue V dye injection

  • L. Barthelmes

      Affiliations

    • Department of Surgery, School of Medicine, Cardiff University, Cardiff CF 14 4XW, United Kingdom
    • Corresponding Author InformationCorresponding author. Tel./fax: +44 2920762968.
    • ,
  • A. Goyal

      Affiliations

    • Department of Surgery, School of Medicine, Cardiff University, Cardiff CF 14 4XW, United Kingdom
    • ,
  • P. Sudheer

      Affiliations

    • Department of Anaesthetics, University Hospital of Wales Heath Park, Cardiff CF14 4XW, United Kingdom
    • ,
  • R.E. Mansel

      Affiliations

    • Department of Surgery, School of Medicine, Cardiff University, Cardiff CF 14 4XW, United Kingdom

Received 6 January 2010 ,Revised 19 April 2010 ,Accepted 25 May 2010.

References 

  1. Barthelmes L, Goyal A, McNeill F et al. Adverse reactions to patent blue V dye - The NEW START and ALMANAC experience. Eur J Surg Oncol 2009 10.1016/j.ejso.2009.10.007, in press.
  2. Barbaud A, Reichert-Penetrat S, Trechot P, Jacquin-Petit MA, Ehlinger A, Noirez V, et al. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol. 1998;139:49–58
  3. Sleth JC. Anaphylaxis due to patent blue. Time to change dye?. Ann Fr Anesth Reanim. 2008;27:515
  4. Mertes PM, Malinovsky JM, Mouton-Faivre C, Bonnet-Boyer MC, Benhaijoub A, Lavaud F, et al. Anaphylaxis to dyes during the perioperative period: reports of 14 clinical cases. J Allergy Clin Immunol. 2008;122:348–352
  5. Lanitis S, Filippakis G, Sidhu V, et al. Atypical anaphylactic reaction to patent blue during sentinel lymph node biopsy for breast cancer. Ann R Coll Surg Engl. 2008;90:338–339
  6. Thierrin L, Steiger D, Zuber JP, Spertini F, Brunisholz Y, Delaloye JF. Severe anaphylactic shock to patent blue V with cardiac arrest during breast carcinoma surgery with lymphatic mapping. Eur J Obs Gyn Repr Biol. 2008;140(1):140–141
  7. Keller B, Yawalkar N, Pichler C. Hypersensitivity reaction against patent blue during sentinel lymph node removal in three melanoma patients. Am J Surg. 2007;193(1):122–124
  8. Hadar T, Gimmon Z, Shalit M. Giant blue urticaria following injection of patent blue dye for sentinel lymph node biopsy. Plast Reconstr Surg. 2006;117(5):1657–1659
  9. Dewachter P, Mouton-Faivre C, Benhaijoub A, Abel-Decollogne F, Mertes PM. Anaphylactic reaction to patent blue V after sentinel lymph node biopsy. Acta Anaesthesiol Scand. 2006;50(2):245–247
  10. van Zuuren E, Polderman MC, Kuijken I. Anaphylaxis to patent blue during sentinel lymph node identification. Contact Dermat. 2005;53:171
  11. Beenen E, de Roy van Zuidewijn DB. Patients blue on patent blue: an adverse reaction during four sentinel node procedures. Surg Oncol. 2005;14(4):151–154
  12. Olsha A, Carmon M. Blue hives localized to the opposite arm after patent blue v injection for lymph node mapping in breast cancer. Breast J. 2005;11(6):468
  13. Noirot A, Vigneau A, Salengro A, Bonnet F. [Allergic reaction to patent blue dye for sentinel lymph node detection during uterus oncological surgery]. Ann Fr Anesth Reanim. 2005;24(5):541–542
  14. Wohrl S, Focke M, Hinterhuber G, Stingl G, Binder M. Near-fatal anaphylaxis to patent blue V. Br J Dermatol. 2004;150:1037–1038
  15. Bouman EA, Songun I, Marcus MA. A case of an anaphylactic reaction to an old substance–patent blue–for a new indication. Acta Anaesth Scand. 2004;48(8):1066
  16. Galatius H, Holtveg HM, Folsgard SL. Anaphylactic reactions to patent blue in sentinel node biopsy for breast cancer. Ugeskr Læger. 2003;165:3242–3243
  17. Forschner K, Kleine-Tebbe A, Zuberbier T, Worm M. Type I sensitization towards patent blue as a cause of anaphylaxis. Allergy. 2003;58:457–458
  18. Crivellaro MJ. Invest Allergol Clin Immunol. 2003;13(1):71–72
  19. Vrancken Peeters MJ, Boutkan H, Lagaay MB, Agsteribbe MJ, Breslau PJ. Anaphylaxis to patient blue during sentinel node biopsy. Eur J Surg Oncol. 2000;26:431
  20. Mullan MH, Deacock SJ, Quiney NF, Kissin MW. Anaphylaxis to patent blue dye during sentinel lymph node biopsy for breast cancer. Eur J Surg Oncol. 2001;27:218–219
  21. van der Horst JC, de Bock MJJM, Klinkenbijl JH. Anafylactische shock na injectie van patentblauw voor schildklierwacht onderzoek. Ned Tijdschr Geneeskd. 2001;145:2086–2088
  22. Woltsche-Kahr I, Komericki P, Kranke B, Brabek E, Horn M, Schuller-Petrovic S, et al. Anaphylactic shock following peritumoral injection of patent blue in sentinel lymph node biopsy procedure. Eur J Surg Oncol. 2000;26:313–314
  23. Salvat J, Margonari H, Hardelin D. Anaphylactic shock due to “patent blue” used to search for the sentinel node. J Gyn Obstetr Biol Repr. 1999;28(4):393–394
  24. Van Vaerenbergh PM. Immediate hypersensitivity after injection of patent blue violet. J Belge Radiol. 1967;50(5):411–412
  25. Laxenaire MC. Epidemiology of anesthetic anaphylactoid reactions. Fourth multicenter survey July 1994-December 1996). Ann Fr Anesth Reanim. 1999;18(7):796–809
  26. Payne V, Kam PC. Mast cell tryptase: a review of its physiology and clinical significance. Anaesthesia. 2004;59(7):695–703
  27. Mertes PM, Laxenaire MC, Alla F. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999–2000. Anesthesiology. 2003;99:536–545
  28. Fisher MM, Baldo BA. Mast cell tryptase in anaesthetic anaphylactoid reactions. Br J Anaesth. 1998;80:26–29
  29. Harper NJ, Dixon T, Dugue P, Edgar DM, Fay A, Gooi HC, et al. Suspected anaphylactic reactions associated with anaesthesia. Working Party of the Association of Anaesthetists of Great Britain and Ireland. Anaesthesia. 2009;64(2):199–211
  30. Reid MJ, Lockey RF, Turkeltaub PC, Platts-Mills TA. Survey of fatalities from skin testing and immunotherapy 1985-1989. J Allergy Clin Immun. 1993;92:6–15
  31. Raut CP, Hunt KK, Akins JS, Daley MD, Ross MI, Singletary SE, et al. Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis: results of a surgical prospective clinical practice protocol. Cancer. 2005;104:692–699
  32. Kalimo K, Jansen CT, Kormano M. Sensitivity to Patent Blue dye during skin-prick testing and lymphography. A retrospective and prospective study. Radiology. 1981;141(2):365–367
  33. Goyal A, Newcombe RG, Chhabra A, Mansel RE. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer–results of the ALMANAC validation phase. Breast Cancer Res Treat. 2006;99:203–208
  34. http://www.aagbi.org/publications/guidelines/docs/anaphylaxis03.pdf[accessed 10.09.09]

PII: S0960-9776(10)00148-7

doi: 10.1016/j.breast.2010.05.016

The Breast
Volume 19, Issue 6 , Pages 516-520 , December 2010

Article Tools

* Image Usage & Resolution